QurAlis Announces Development Candidate for ALS Targeting STATHMIN-2 ...Middle East

CAMBRIDGE, Mass., Sept. 14, 2021 /PRNewswire/ -- QurAlis Corporation, a biotech company developing breakthrough precision medicines for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases with genetically validated targets, today announced the nomination of QRL-201 as...

Hence then, the article about quralis announces development candidate for als targeting stathmin 2 was published today ( Wednesday 15/09/2021 - 12:00 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( QurAlis Announces Development Candidate for ALS Targeting STATHMIN-2 )

Also on site :

• Britney Spears Spends Time With Diane Warren and Molly Shannon After DUI
• This Guitarist Helped Shape One of the Most Iconic Sounds of the '90s
• 'You should resign': Mamata hits out at PM Modi's silence on Pakistan's threat to strike Kolkata